These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23193364)

  • 1. Peroxisome proliferator-activated receptors in regulation of cytochromes P450: new way to overcome multidrug resistance?
    Cizkova K; Konieczna A; Erdosova B; Lichnovska R; Ehrmann J
    J Biomed Biotechnol; 2012; 2012():656428. PubMed ID: 23193364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of PPARs in MDR - a lesson from embryonic development.
    Konieczna A; Lichnovka R; Erdosova B; Ehrmann J
    Neoplasma; 2009; 56(4):279-83. PubMed ID: 19469651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modulation of nuclear receptors on drug-metabolizing enzymes and transporters].
    Liu ZH; Li Y
    Yao Xue Xue Bao; 2012 Dec; 47(12):1575-81. PubMed ID: 23460960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor ɑ (PPARɑ)-cytochrome P450 epoxygenases-soluble epoxide hydrolase axis in ER + PR + HER2- breast cancer.
    Tauber Z; Koleckova M; Cizkova K
    Med Mol Morphol; 2020 Sep; 53(3):141-148. PubMed ID: 31823010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X; Zhang XA; Wang DW
    Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology.
    Wray J; Bishop-Bailey D
    Exp Physiol; 2008 Jan; 93(1):148-54. PubMed ID: 17872966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent expression of cytochrome p450 epoxygenases during human prenatal development.
    Cizkova K; Konieczna A; Erdosova B; Ehrmann J
    Organogenesis; 2014 Jan; 10(1):53-61. PubMed ID: 24492490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
    Cizkova K; Tauber Z
    Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome Proliferator-Activated Receptor α Activation Suppresses Cytochrome P450 Induction Potential in Mice Treated with Gemfibrozil.
    Shi C; Min L; Yang J; Dai M; Song D; Hua H; Xu G; Gonzalez FJ; Liu A
    Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):169-174. PubMed ID: 28374976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner.
    Cizkova K
    Toxicol Appl Pharmacol; 2018 Sep; 355():156-163. PubMed ID: 29960002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of PPARs in Disease.
    Wagner N; Wagner KD
    Cells; 2020 Oct; 9(11):. PubMed ID: 33126411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 Induction and Xeno-Sensing Receptors Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor α at the Crossroads of Toxicokinetics and Toxicodynamics.
    Hakkola J; Bernasconi C; Coecke S; Richert L; Andersson TB; Pelkonen O
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():42-50. PubMed ID: 29527807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Yousefi B; Samadi N; Baradaran B; Rameshknia V; Shafiei-Irannejad V; Majidinia M; Targhaze N; Zarghami N
    Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):118-22. PubMed ID: 26718439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.
    Lamichane S; Dahal Lamichane B; Kwon SM
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brain.
    Stocco MR; Tyndale RF
    Adv Pharmacol; 2022; 95():73-106. PubMed ID: 35953164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells.
    Yousefi B; Azimi A; Majidinia M; Shafiei-Irannejad V; Badalzadeh R; Baradaran B; Zarghami N; Samadi N
    Tumour Biol; 2017 Oct; 39(10):1010428317716501. PubMed ID: 28978268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors and angiogenesis.
    Biscetti F; Straface G; Pitocco D; Zaccardi F; Ghirlanda G; Flex A
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):751-9. PubMed ID: 19628379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.